Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 785825, 9 pages
http://dx.doi.org/10.1155/2012/785825
Research Article

Toll-Like Receptor Transcriptome in the HPV-Positive Cervical Cancer Microenvironment

1Probe Development and Biomarker Exploration Thunder Bay Regional Research Institute, Thunder Bay, ON, Canada P7B 6V4
2Biorefining Research Initiative and Department of Biology, Lakehead University, Thunder Bay, ON, Canada P7B 5E1
3Thunder Bay Regional Health Sciences Centre, Department of Pathology, Thunder Bay, ON, Canada P7B 6V4

Received 12 May 2011; Accepted 6 July 2011

Academic Editor: Ludovica Segat

Copyright © 2012 Correne A. DeCarlo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Sato, Y. Goto, N. Narita, and D. S. B. Hoon, “Cancer cells expressing toll-like receptors and the tumor microenvironment,” Cancer Microenvironment, vol. 2, no. 1, pp. S205–S214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Akira and K. Takeda, “Toll-like receptor signalling,” Nature Reviews Immunology, vol. 4, no. 7, pp. 499–511, 2004. View at Google Scholar · View at Scopus
  3. A. Isaacs and J. Lindenmann, “Virus interference. I. The interferon,” Proceedings of the Royal Society of London. Series B, vol. 147, no. 927, pp. 258–267, 1957. View at Google Scholar
  4. A. Takaoka, S. Hayakawa, H. Yanai et al., “Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence,” Nature, vol. 424, no. 6948, pp. 516–523, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. D. B. Stetson and R. Medzhitov, “Type I Interferons in Host Defense,” Immunity, vol. 25, no. 3, pp. 373–381, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Pestka, J. A. Langer, K. C. Zoon, and C. E. Samuel, “Interferons and their actions,” Annual Review of Biochemistry, vol. 56, pp. 727–777, 1987. View at Google Scholar · View at Scopus
  7. E. A. Bach, M. Aguet, and R. D. Schreiber, “The IFNγ receptor: a paradigm for cytokine receptor signaling,” Annual Review of Immunology, vol. 15, pp. 563–591, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. D. W. LaFleur, B. Nardelli, T. Tsareva et al., “Interferon-κ, a novel type I interferon expressed in human keratinocytes,” Journal of Biological Chemistry, vol. 276, no. 43, pp. 39765–39771, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. P. J. Buontempo, R. G. Jubin, C. A. Buontempo, N. E. Wagner, G. R. Reyes, and B. M. Baroudy, “Antiviral activity of transiently expressed IFN-κ is cell-associated,” Journal of Interferon and Cytokine Research, vol. 26, no. 1, pp. 40–52, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Alexopoulou, A. C. Holt, R. Medzhitov, and R. A. Flavell, “Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3,” Nature, vol. 413, no. 6857, pp. 732–738, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Heil, H. Hemmi, H. Hochrein et al., “Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8,” Science, vol. 303, no. 5663, pp. 1526–1529, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Hemmi, O. Takeuchi, T. Kawai et al., “A Toll-like receptor recognizes bacterial DNA,” Nature, vol. 408, no. 6813, pp. 740–745, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Janssens and R. Beyaert, “Role of Toll-like receptors in pathogen recognition,” Clinical Microbiology Reviews, vol. 16, no. 4, pp. 637–646, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Takeuchi, T. Kawai, P. F. Mühlradt et al., “Discrimination of bacterial lipoproteins by Toll-like recepttor 6,” International Immunology, vol. 13, no. 7, pp. 933–940, 2001. View at Google Scholar · View at Scopus
  15. O. Takeuchi, S. Sato, T. Horiuchi et al., “Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins,” Journal of Immunology, vol. 169, no. 1, pp. 10–14, 2002. View at Google Scholar · View at Scopus
  16. K. Farhat, S. Riekenberg, H. Heine et al., “Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling,” Journal of Leukocyte Biology, vol. 83, no. 3, pp. 692–701, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Hayashi, K. D. Smith, A. Ozinsky et al., “The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5,” Nature, vol. 410, no. 6832, pp. 1099–1103, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. A. T. Gewirtz, T. A. Navas, S. Lyons, P. J. Godowski, and J. L. Madara, “Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression,” Journal of Immunology, vol. 167, no. 4, pp. 1882–1885, 2001. View at Google Scholar · View at Scopus
  19. R. Chen, A. B. Alvero, D. A. Silasi, K. D. Steffensen, and G. Mor, “Cancers take their Toll—the function and regulation of Toll-like receptors in cancer cells,” Oncogene, vol. 27, no. 2, pp. 225–233, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Zur Hausen, “Papillomaviruses in human cancer,” Applied Pathology, vol. 5, no. 1, pp. 19–24, 1987. View at Google Scholar · View at Scopus
  21. S. Li, S. Labrecque, M. C. Gauzzi et al., “The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α,” Oncogene, vol. 18, no. 42, pp. 5727–5737, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. E. Chang and L. A. Laimins, “Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31,” Journal of Virology, vol. 74, no. 9, pp. 4174–4182, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. I. I. Daud, M. E. Scott, Y. Ma, S. Shiboski, S. Farhat, and A. B. Moscicki, “Association between toll-like receptor expression and human papillomavirus type 16 persistence,” International Journal of Cancer, vol. 128, no. 4, pp. 879–886, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Yu, L. Wang, M. Li, J. Zhong, Z. Wang, and S. Chen, “Expression of toll-like receptor 4 is down-regulated during progression of cervical neoplasia,” Cancer Immunology, Immunotherapy, vol. 59, no. 7, pp. 1021–1028, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. U. A. Hasan, E. Bates, F. Takeshita et al., “TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16,” Journal of Immunology, vol. 178, no. 5, pp. 3186–3197, 2007. View at Google Scholar · View at Scopus
  26. C. A. Decarlo, A. Severini, L. Edler et al., “IFN-κ, a novel type i IFN, is undetectable in HPV-positive human cervical keratinocytes,” Laboratory Investigation, vol. 90, no. 10, pp. 1482–1491, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. C. A. DeCarlo, N. G. Escott, J. Werner et al., “Gene expression analysis of interferon κ in laser capture microdissected cervical epithelium,” Analytical Biochemistry, vol. 381, no. 1, pp. 59–66, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M. E. Scott, Y. Ma, L. Kuzmich, and A. B. Mescicki, “Diminished IFN-γ and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3,” International Journal of Cancer, vol. 124, no. 6, pp. 1379–1383, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Y. Kim, J. W. Lee, J. J. Choi et al., “Increased expression of Toll-like receptor 5 during progression of cervical neoplasia,” International Journal of Gynecological Cancer, vol. 18, no. 2, pp. 300–305, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Gey, P. Kumari, A. Sambandam et al., “Identification and characterisation of a group of cervical carcinoma patients with profound downregulation of intratumoral Type 1 (IFNγ) and Type 2 (IL-4) cytokine mRNA expression,” European Journal of Cancer, vol. 39, no. 5, pp. 595–603, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. J. M. Alcocer-González, J. Berumen, R. Taméz-Guerra et al., “In vivo expression of immunosuppressive cytokines in human papillomavirus-transfonned cervical cancer cells,” Viral Immunology, vol. 19, no. 3, pp. 481–491, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Rincon-Orozco, G. Halec, S. Rosenberger et al., “Epigenetic silencing of interferon-κ in human papillomavirus type 16-positive cells,” Cancer Research, vol. 69, no. 22, pp. 8718–8725, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Nees, J. M. Geoghegan, T. Hyman, S. Frank, L. Miller, and C. D. Woodworth, “Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-κB-responsive genes in cervical keratinocytes,” Journal of Virology, vol. 75, no. 9, pp. 4283–4296, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. J. W. Lee, J. J. Choi, S. S. Eun et al., “Increased toll-like receptor 9 expression in cervical neoplasia,” Molecular Carcinogenesis, vol. 46, no. 11, pp. 941–947, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. M. M. Herbst-Kralovetz, A. J. Quayle, M. Ficarra et al., “Quantification and comparison of toll-like receptor expression and responsiveness in primary and immortalized human female lower genital tract epithelia,” American Journal of Reproductive Immunology, vol. 59, no. 3, pp. 212–224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. C. C. Pao, C. Y. Lin, D. S. Yao, and C. J. Tseng, “Differential expression of cytokine genes in cervical cancer tissues,” Biochemical and Biophysical Research Communications, vol. 214, no. 3, pp. 1146–1151, 1995. View at Publisher · View at Google Scholar · View at Scopus
  37. T. D. De Gruijl, H. J. Bontkes, A. J. C. Van den Muysenberg et al., “Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix,” European Journal of Cancer, vol. 35, no. 3, pp. 490–497, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. I. Zehbe, E. Rylander, K. Edlund, G. Wadell, and E. Wilander, “Detection of human papillomavirus in cervical intra-epithelial neoplasia, using in situ hybridization and various polymerase chain reaction techniques,” Virchows Archiv, vol. 428, no. 3, pp. 151–157, 1996. View at Google Scholar · View at Scopus
  39. C. F. A. Culling, R. T. Allison, and W. T. Barr, “Cellular pathology techniques,” in Microorganisms, pp. 55–59, Butterworths & Co., London, UK, 4th edition, 1985. View at Google Scholar
  40. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Hollander and D. A. Wolfe, Nonparametric Statistical Methods, Wiley-Interscience, Hoboken, NJ, USA, 2nd edition, 1999.
  42. M. A. Stanley, M. R. Pett, and N. Coleman, “HPV: from infection to cancer,” Biochemical Society Transactions, vol. 35, no. 6, pp. 1456–1460, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Gius, M. C. Funk, E. Y. Chuang et al., “Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates,” Cancer Research, vol. 67, no. 15, pp. 7113–7123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Manavi, G. Hudelist, A. Fink-Retter, D. Gschwandtler-Kaulich, K. Pischinger, and K. Czerwenka, “Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma,” Gynecologic Oncology, vol. 105, no. 2, pp. 418–426, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. L. V. Ronco, A. Y. Karpova, M. Vidal, and P. M. Howley, “Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity,” Genes and Development, vol. 12, no. 13, pp. 2061–2072, 1998. View at Google Scholar · View at Scopus
  46. J. J. Khoo, S. Forster, and A. Mansell, “Toll-like receptors as interferon-regulated genes and their role in disease,” Journal of Interferon and Cytokine Research, vol. 31, no. 1, pp. 13–25, 2011. View at Publisher · View at Google Scholar
  47. V. Dell'Oste, B. Azzimonti, M. Mondini et al., “Altered expression of UVB-induced cytokines in human papillomavirus-immortalized epithelial cells,” Journal of General Virology, vol. 89, no. 10, pp. 2461–2466, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. N. Dietrich, S. Lienenklaus, S. Weiss, and N. O. Gekara, “Murine Toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartments,” PLoS One, vol. 5, no. 4, Article ID e10250, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Mohan and J. Zhu, “Toll-like receptor signaling pathways—therapeutic opportunities,” Mediators of Inflammation, vol. 2010, Article ID 781235, 7 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. E. Y. So and T. Ouchi, “The application of toll like receptors for cancer therapy,” International Journal of Biological Sciences, vol. 6, no. 7, pp. 675–681, 2010. View at Google Scholar · View at Scopus